Literature DB >> 6206349

Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system.

D Regoli.   

Abstract

Bradykinin and related kinins are potent vasodilators. Inhibition of peripheral vascular smooth-muscle tone may result from actions of kinins at different levels. These include the afferent nociceptive nerve endings (bradykinin being a potent algesic agent); the brain and the spinal cord; and the three basic structural components of resistance vessels, namely, endothelium, smooth-muscle fibers, and autonomic nerve endings. The relative roles and the importance of these various structures and the mechanisms for the vasodilator and hypotensive effects of the kinins are discussed. Attention is focused on data obtained in isolated vascular beds, perfused with physiological media, and in strips or segments of arterial and venous vessels, suspended in vitro. Bradykinin and related kinins are potent vasodilators in the majority of peripheral vascular beds of various species, although they contract some isolated arteries and all the veins. These opposite vascular effects of the kinins appear to be mediated by at least two different receptor types, which have been identified and characterized with a series of kinin agonists and some kinin antagonists. B1-receptors mediate the contraction of arterial and venous smooth muscles, while B2-receptors are involved in the relaxation of arteries, the contraction of veins, and the increase in vascular permeability produced by kinins. Hypotension generally results from activation of B2-receptors, B1-receptors intervening only in special conditions. The relaxing effect of kinins in isolated arteries (B2-receptors) occurs only in the presence of endothelium, whereas all the stimulations do not require endothelium and appear to be owing to the activation of B2- and B1-receptors in the membranes of vascular smooth-muscle cells. It is still unknown whether endothelium is involved in the hypotensive and peripheral vasodilator actions of kinins in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206349     DOI: 10.1097/00005344-198406002-00015

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  15 in total

1.  Angioedema induced by tramadol--a potentially life-threatening condition.

Authors:  Pär Hallberg; Gunilla Brenning
Journal:  Eur J Clin Pharmacol       Date:  2005-01-19       Impact factor: 2.953

2.  Effect of a crude extract of Mandevilla velutina on contractions induced by bradykinin and [des-Arg9]-bradykinin in isolated vessels of the rabbit.

Authors:  J B Calixto; R A Yunes
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

3.  Long-term hypoxia uncouples Ca2+ and eNOS in bradykinin-mediated pulmonary arterial relaxation.

Authors:  Carla Blum-Johnston; Richard B Thorpe; Chelsea Wee; Raechel Opsahl; Monica Romero; Samuel Murray; Alexander Brunelle; Quintin Blood; Rachael Wilson; Arlin B Blood; Lubo Zhang; Lawrence D Longo; William J Pearce; Sean M Wilson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-07       Impact factor: 3.619

4.  Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice.

Authors:  Y Fujimori; T Nakamura; K Shimizu; T Yamamuro; K Wanaka; S Okamoto; Y Katsuura
Journal:  Agents Actions       Date:  1993-05

Review 5.  The kinin system in hypertensive pathophysiology.

Authors:  Jagdish N Sharma
Journal:  Inflammopharmacology       Date:  2012-04-17       Impact factor: 4.473

6.  Cerebrovascular effects of the bradykinin analog RMP-7 in normal and irradiated dog brain.

Authors:  J R Fike; G T Gobbel; A H Mesiwala; H J Shin; M Nakagawa; K R Lamborn; T M Seilhan; P J Elliott
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

7.  Segmental expression of the bradykinin type 2 receptor in rat efferent ducts and epididymis and its role in the regulation of aquaporin 9.

Authors:  C Belleannée; N Da Silva; W W C Shum; M Marsolais; R Laprade; D Brown; S Breton
Journal:  Biol Reprod       Date:  2008-10-01       Impact factor: 4.285

8.  Cardiovascular effects of intrathecally administered bradykinin in the rat: characterization of receptors with antagonists.

Authors:  P Lopes; D Regoli; R Couture
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

9.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.

Authors:  F J Hock; K Wirth; U Albus; W Linz; H J Gerhards; G Wiemer; S Henke; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

10.  Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.

Authors:  P Bélichard; B Loillier; J L Paquet; J M Luccarini; D Pruneau
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.